Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.089 USD | +5.95% |
|
+4.71% | -48.53% |
Jul. 01 | Nascent Biotech, Inc. Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
Apr. 16 | Nascent Biotech, Inc. Prepares for Pivotal Phase II Research with Fresh Manufacturing Run | CI |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
NASCENT BIOTECH, INC. | Bio Therapeutic Drugs | +5.95% | +4.71% | -48.53% | +88.96% | -55.05% | 15.33M | - | - | - |
- Stock Market
- Equities
- NBIO Stock
- Charts Nascent Biotech, Inc.
- Relative Strength Chart